Frequency ExchangeCorp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), will receive the first order of 5,000 personal wellness and performance devices the "NIKKI" on or about November 21st, 2022, valued at $1,250,000 in gross revenue at retail. FREmedica has just confirmedit has secured the timelinefor its next order for 25,000 NIKKIs with a projected delivery date at the end of the first quarter, 2023.

The results of ‘Quality of Life /Proof of Concept' trial have set the stage to help millions of people who are struggling with issues related to sleep, pain & inflammation, lackof energy, stress& anxiety or a combination of all of the above. NIKKI is a first-of-its-kind frequency emitter that delivers frequencies into the body designed for wellness and performance enhancement.